EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy

Cristina Royo-Cebrecos iD, Júlia Laporte-Amargós iD, Marta Peña, Isabel Ruiz-Camps iD, Carolina Garcia-Vidal iD, Edson Abdala, Chiara Oltolini, Murat Akova, Miguel Montejo, Malgorzata Mikulska, Pilar Martín-Dávila, Fabián Herrera und 27 weitere

Microorganisms · 30.03.2024 · 12 (4) · 705

DOI: 10.3390/microorganisms12040705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 30.03.2024. Verfasst von Cristina Royo-Cebrecos und 38 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Hospital Nostra Senyora de Meritxell, SAAS, AD700 Escaldes-Engordany, Andorra. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This large, multicenter, retrospective cohort study including onco-hematological neutropenic patients with Pseudomonas aeruginosa bloodstream infection (PABSI) found that among 1213 episodes, 411 (33%) presented with septic shock. The presence of solid tumors (33.3% vs. 20.2%, p < 0.001), a high-risk Multinational Association for Supportive Care in Cancer (MASCC) index score (92.6% vs. 57.4%; p < 0.001), pneumonia (38% vs. 19.2% p < 0.001), and infection due to multidrug-resistant P. aeruginosa (MDRPA) (33.8% vs. 21.1%, p < 0.001) were statistically significantly higher in patients with septic shock compared to those without. Patients with septic shock were more likely to receive inadequate empirical antibiotic therapy (IEAT) (21.7% vs. 16.2%, p = 0.020) and to present poorer outcomes, including a need for ICU admission (74% vs. 10.5%; p < 0.001), mechanical ventilation (49.1% vs. 5.6%; p < 0.001), and higher 7-day and 30-day case fatality rates (58.2% vs. 12%, p < 0.001, and 74% vs. 23.1%, p < 0.001, respectively). Risk factors for 30-day case fatality rate in patients with septic shock were orotracheal intubation, IEAT, infection due to MDRPA, and persistent PABSI. Therapy with granulocyte colony-stimulating factor and BSI from the urinary tract were associated with improved survival. Carbapenems were the most frequent IEAT in patients with septic shock, and the use of empirical combination therapy showed a tendency towards improved survival. Our findings emphasize the need for tailored management strategies in this high-risk population.

Schlagwörter

Stichwörter der Autor:innen

Pseudomonas aeruginosabacteremiabloodstream infectioncancerneutropeniaseptic shock

Autor:innen und Institutionen

  • Internal Medicine Department, Hospital Nostra Senyora de Meritxell, SAAS, AD700 Escaldes-Engordany, Andorra.
  • Infectious Diseases Department, Bellvitge University Hospital, IDIBELL, 08907 Barcelona, Spain.
  • Haematology Department, Institute Català d'Oncologia (ICO)-Hospital Duran i Reynals, IDIBELL, 08908 Barcelona, Spain.
  • Infectious Diseases Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
  • Infectious Diseases Department, Hospital Clínic i Provincial, 08036 Barcelona, Spain.
  • Instituto do Cancer do Estado de São Paulo, Faculty of Medicine, Univesity of São Paulo, Sao Paulo 01246, Brazil.

ORCID-Profile: Cristina Royo-Cebrecos, Júlia Laporte-Amargós, Isabel Ruiz-Camps, Carolina Garcia-Vidal, Zaira R Palacios-Baena, Souha S Kanj, Jorge I Marin, Maddalena Peghin, Jose L Del Pozo, Jordi Carratalà

Förderung

  • Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC)

Zitieren

APA

Royo-Cebrecos, C., Laporte-Amargós, J., Peña, M., Ruiz-Camps, I., Garcia-Vidal, C., Abdala, E., Oltolini, C., Akova, M., Montejo, M., Mikulska, M., Martín-Dávila, P., Herrera, F., Gasch, O., Drgona, L., Morales, H. M. P., Brunel, A. S., García, E., Isler, B., Kern, W. V., …, & IRONIC Study Group (2024). Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy. Microorganisms, 12(4), 705. https://doi.org/10.3390/microorganisms12040705

Vancouver

Royo-Cebrecos C, Laporte-Amargós J, Peña M, Ruiz-Camps I, Garcia-Vidal C, Abdala E, et al. Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy. Microorganisms. 2024;12(4):705. doi:10.3390/microorganisms12040705

BibTeX
@article{RoyoCebrecos2024,
  author = {Royo-Cebrecos, Cristina and Laporte-Amargós, Júlia and Peña, Marta and Ruiz-Camps, Isabel and Garcia-Vidal, Carolina and Abdala, Edson and Oltolini, Chiara and Akova, Murat and Montejo, Miguel and Mikulska, Malgorzata and Martín-Dávila, Pilar and Herrera, Fabián and Gasch, Oriol and Drgona, Lubos and Morales, Hugo Manuel Paz and Brunel, Anne-Sophie and García, Estefanía and Isler, Burcu and Kern, Winfried V and Palacios-Baena, Zaira R and de la Calle, Guillermo Maestr and Montero, Maria Milagro and Kanj, Souha S and Sipahi, Oguz R and Calik, Sebnem and Márquez-Gómez, Ignacio and Marin, Jorge I and Gomes, Marisa Z R and Hemmatii, Philipp and Araos, Rafael and Peghin, Maddalena and Del Pozo, Jose L and Yáñez, Lucrecia and Tilley, Robert and Manzur, Adriana and Novo, Andrés and Carratalà, Jordi and Gudiol, Carlota and IRONIC Study Group, IRONIC Study Group},
  title = {Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy},
  journal = {Microorganisms},
  year = {2024},
  volume = {12},
  number = {4},
  pages = {705},
  doi = {10.3390/microorganisms12040705}
}
Kostenlos starten →